Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Rheumatic Diseases Clinics of North America|September 6, 2001
Antiphospholipid antibodies and the coagulation cascadeE Anglés-Cano, M C GuillinChemistry and Physics of Lipids|January 1, 1994
Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfacesE Anglés-CanoBrazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 9, 1998
Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic processE Anglés-CanoThrombosis Research|June 1, 1988
A method for the determination of the affinity constant of antibodies to tissue plasminogen activatorE Genot, E Anglés-CanoThe Biochemical Journal|October 1, 1990
The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasminD Rouy, E Anglés-CanoBiochemistry|July 30, 1991
Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysinesV Fleury, E Anglés-CanoBiochimica Et Biophysica Acta|September 20, 1991
The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1P Gaussem, E Anglés-CanoEuropean Journal of Biochemistry|February 1, 1994
Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogenP Grailhe, W Nieuwenhuizen, E Anglés-CanoThe Journal of Biological Chemistry|June 5, 1993
Sodium dodecyl sulfate-induced dissociation of complexes between human tissue plasminogen activator and its specific inhibitorP Gaussem, P Grailhe, E Anglés-CanoThe Journal of Biological Chemistry|September 5, 1993
Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysisV Fleury, H R Lijnen, E Anglés-CanoPageof 10